Cargando…
Neuroblastoma Screening at 1 Year of Age: The Final Results of a Controlled Trial
BACKGROUND: Neuroblastoma screening aims to reduce neuroblastoma-related mortality. A controlled trial showed no reduction in stage 4 disease incidence and preliminary mortality data. This article presents epidemiologic and clinical data 20 years after cessation of the screening program. METHODS: Th...
Autores principales: | Berthold, Frank, Spix, Claudia, Erttmann, Rudolf, Hero, Barbara, Michaelis, Joerg, Treuner, Joern, Ernst, Angela, Schilling, Freimut H |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8259619/ https://www.ncbi.nlm.nih.gov/pubmed/34240006 http://dx.doi.org/10.1093/jncics/pkab041 |
Ejemplares similares
-
Long-term outcomes of the GPOH NB97 trial for children with high-risk neuroblastoma comparing high-dose chemotherapy with autologous stem cell transplantation and oral chemotherapy as consolidation
por: Berthold, Frank, et al.
Publicado: (2018) -
Correction: Long-term outcomes of the GPOH NB97 trial for children with high-risk neuroblastoma comparing high-dose chemotherapy with autologous stem cell transplantation and oral chemotherapy as consolidation
por: Berthold, Frank, et al.
Publicado: (2019) -
Incidence, Survival, and Treatment of Localized and Metastatic Neuroblastoma in Germany 1979–2015
por: Berthold, Frank, et al.
Publicado: (2017) -
A new risk score for patients after first recurrence of stage 4 neuroblastoma aged ≥18 months at first diagnosis
por: Kreitz, Kiana, et al.
Publicado: (2019) -
Genetic Alterations and Resectability Predict Outcome in Patients with Neuroblastoma Assigned to High-Risk Solely by MYCN Amplification
por: Berthold, Frank, et al.
Publicado: (2021)